The INTRICATE platform is a strategic platform biomedical nanotechnology to develop assets in the field of regenerative medicine. It is a novel compound that is turned into a self-curing, biocompatible 3D printable bio-ink.
INTRICATE stands for
- Regeneration for
Our leading technology, effectuates a dual mode of action by providing a natural, biocompatible extracellular matrix, stimulating cell proliferation, as well as being a carrier for selected compounds. We have observed encouraging regeneration in various tissue types in preclinical models both with and without additional compounds.
The development strategy for INTRICATE is a pipeline in product, to advance multiple INTRICATE candidates across different selectivity profiles, and to test these in a broad panel of in vivo degenerative disease and traumatic models targeting a number of indications, with a key focus on tissue regeneration.